• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

UBS Hosts 2007 Global Generic and Specialty Pharmaceuticals Conference

Posted on: Wednesday, 25 April 2007, 12:00 CDT

UBS:

WHAT: The 2007 UBS Global Generic and Specialty Pharmaceuticals Conference will feature presentations from over 90 pharmaceutical companies from around the globe including drug delivery, generic and other specialty pharmaceuticals. The preliminary list of presenting companies includes:

North America

Stiefel Laboratories, Inc. (Private, USA)

Akorn, Inc. (Public, USA)

TransOral Pharmaceuticals Inc. (Private, USA)

Alliant Pharmaceuticals, Inc. (Private, USA)

Unigene Laboratories Inc. (Public, USA)

Alpharma, Inc. (Public, USA)

URL/Mutual Pharmaceutical Company (Private, USA)

Antigenics Inc. (Public, USA)

Victory Pharma, Inc. (Private, USA)

Arena Pharmaceuticals, Inc. (Public, USA)

Latin America / Brazil

Axcan Pharma Inc. (Public, Canada)

Biolab Sanus (Private, Brazil)

Auxilium Pharmaceuticals, Inc. (Public, USA)

Farmasa Laboratório Americano de Farmacoterapia S.A. (Private, Brazil)

Bentley Pharmaceuticals, Inc. (Public, USA)

Grupo EMS Sigma Farma (Private, Brazil)

Bioenvision, Inc. (Public, USA)

Laboratorios Silanes, S.A. de C.V. (Private, Mexico)

Biovail Corporation (Public, Canada)

Medley S.A. Indústria Farmacêutica (Private, Brazil)

Bradley Pharmaceuticals, Inc. (Public, USA)

Europe / Russia / Middle East / Africa

Cadence Pharmaceuticals, Inc. (Public, USA)

Actavis Group (Public, Iceland)

Cangene Corporation (Public, Canada)

Deva Holding A.S. (Public, Turkey)

Celgene Corporation (Public, USA)

Eurand S.p.A. (Private, Italy)

Collagenex Pharmaceuticals Inc. (Public, USA)

Flamel Technologies S.A. (Public, France)

CytRx Corporation (Public, USA)

Hikma Pharmaceuticals PLC (Public, Jordan)

DURECT Corporation (Public, USA)

NicOx S.A. (Public, France)

Endo Pharmaceuticals Holdings Inc. (Public, USA)

Novo Nordisk A/S (Public, Denmark)

Geron Corporation (Public, USA)

Omega Pharma NV (Public, Belgium)

Halozyme Therapeutics, Inc. (Public, USA)

Polpharma SA (Private, Poland)

Hi-Tech Pharmacal Co., Inc. (Public, USA)

Recordati S.p.A. (Public, Italy)

Indevus Pharmaceuticals, Inc. (Public, USA)

Skyepharma PLC (Public, UK)

Iomai Corporation (Public, USA)

Sothema (Public, Morocco)

Javelin Pharmaceuticals, Inc. (Public, USA)

Teva Pharmaceutical Industries Ltd. (Public, Israel)

King Pharmaceuticals, Inc. (Public, USA)

Veropharm (Public, Russia)

KV Pharmaceutical Company (Public, USA)

India

Lannett Company, Inc. (Public, USA)

Aurobindo Pharma Ltd. (Public, India)

MannKind Corporation (Public, USA)

Cadila Healthcare Ltd. (Public, India)

Medivation Inc. (Public, USA)

Claris Lifesciences Ltd (Private, India)

MedPointe Pharmaceuticals, Inc. (Private, USA)

Dabur Pharma Ltd. (Public, India)

Mylan Laboratories Inc. (Public, USA)

Glenmark Pharmaceuticals Ltd. (Public, India)

Nastech Pharmaceutical Company, Inc. (Public, USA)

Intas Pharmaceuticals Ltd. (Private, India)

Neurochem, Inc. (Public, Canada)

Nicholas Piramal Limited (Public, India)

Noven Pharmaceuticals, Inc. (Public, USA)

Orchid Chemicals and Pharmaceuticals (Public, India)

Obagi Medical Products, Inc. (Public, USA)

Panacea Biotec Limited (Public, India)

Paladin Labs, Inc. (Public, Canada)

Ranbaxy Laboratories Limited (Public, India)

Penwest Pharmaceutical Co. (Public, USA)

Torrent Pharmaceuticals Ltd. (Public, India)

Pharmascience, Inc. (Private, Canada)

China

POZEN, Inc. (Public, USA)

3sBio, Inc. (Public, China)

Progenics Pharmaceuticals, Inc. (Public, USA)

American Oriental Bioengineering, Inc. (Public, China)

QLT Inc. (Public, Canada)

Hutchison China MediTech Ltd. (Public, China)

Resverlogix Corporation (Public, Canada)

Joincare Pharmaceutical Group Industry Co. Ltd. (Public, China)

Salix Pharmaceuticals, Ltd. (Public, USA)

Perfect Sky (Private, China)

Santarus, Inc. (Public, USA)

Sinovac Biotech Ltd.(Public, China)

Sciele Pharma, Inc. (Public, USA)

Tongjitang Chinese Medicines Company (Public, China)

Sepracor Inc. (Public, USA)

Wuyi International Pharmaceutical Ltd. (Public, China)

SkinMedica, Inc. (Private, USA)

Zhejiang Hisun Pharma Co., Ltd. (Public, China)

Solstice Neurosciences, Inc. (Private, USA)

Somaxon Pharmaceuticals, Inc. (Public, USA)

WHY: The UBS Generic and Specialty Pharmaceuticals Conference is the most global conference of its kind in one of the most rapidly growing sectors in healthcare. 2007 will undoubtedly be a landmark year as cross-border consolidation and globalization continues within the sector. This year's conference will feature presentations from the leading generic and specialty pharma companies from around the world including Western, Central and Eastern Europe, India, China, Brazil and North America.

WHEN: Tuesday, May 8 and Wednesday, May 9, 2007

WHERE: Grand Hyatt New York Park Avenue at Grand Central New York City

WEBCAST: Live audio transmissions of company presentations will be accessible via the UBS Investment Bank website at www.ibb.ubs.com when the conference opens. Replays will be available starting approximately three hours after the initial presentation and will remain accessible for four weeks.

REGISTER: Members of the media may register for the conference by contacting Kris Kagel at kris.kagel@ubs.com or (212) 882-5691.

Source: Business Wire

More News in this Category